bioRxivMicrobiologyPreprint
Ten-year retrospective analysis of Acinetobacter baumannii clinical isolates reveals a proportionately large, non-nosocomial, multidrug-resistant endemic reservoir
Abstract
BackgroundAcinetobacter baumannii (Ab) is a global health threat notorious for causing hospital-acquired (HA) infections, though many Ab infections are community-acquired (CA). Investigations describing contemporaneous, clinically-relevant CA and HA Ab populations, are lacking.\n\nMethodsWe conducted a retrospective ecological analysis of 2042 Ab clinical isolates identified from 2007 to 2017 in the BJC HealthCare System (BJC), a multi-hospital system located in and around the greater metropolitan area in St. Louis, Missouri. We described basic clinical characteristics and antibiotic susceptibility rates of CA and HA Ab isolates in comparative and longitudinal analyses.\n\nResults62.1% of all Ab isolates were CA, i.e., isolated in ambulatory settings or <48 hours following hospital admission. Though HA isolates initially predominated in the largest BJC hospital, implementation of infection control efforts resulted in a disproportionate reduction in annual HA isolate occurrence. This revealed a stable, baseline occurrence of CA isolates. In all other hospitals, the annual proportion of isolates that were CA averaged 78.7% (95%CI=74.5-83.0). 42.9% and 30.4% of total CA isolates were from skin and soft tissue/musculoskeletal (SST/MSK) and urinary sources, respectively, while HA isolates were primarily respiratory (55.6%). Rates of carbapenem resistance, a surrogate for multidrug resistant (MDR) phenotypes, were higher among respiratory and HA cases ([~]60%) compared to contemporaneous non-respiratory CA counterparts ([~]40%).\n\nConclusionsMDR Ab reservoirs associated with SST/MSK and urinary niches persist outside of hospital environments in a large U.S. healthcare system, even after the implementation of effective hospital infection control measures.\n\nSummaryWe compared hospital-acquired and community-acquired Acinetobacter baumannii in a large U.S. healthcare system through a ten-year retrospective ecological analysis. Community-acquired isolates composed over 60% of total A. baumannii isolates, were primarily from non-respiratory sources and exhibited carbapenem resistance rates of 35-40%.
- organism: human
- assay: clinical cohort / trial
- research focus: host-pathogen & immune response
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Monitoring the battlefield: Antimicrobial resistance, antibiofilm patterns and virulence factors of Acinetobacter baumannii isolates from hospital system
S. Awuor·bioRxiv·Dec 14, 2022
- Carbapenem-Resistant Acinetobacter baumannii in US hospitals: diversification of circulating lineages and antimicrobial resistance
A. V. Iovleva, M. M. Mustapha, … Y. Doi·bioRxiv·Sep 21, 2021
- Molecular epidemiology and clone transmission of carbapenem-resistant Acinetobacter baumannii in ICU rooms
Xiufeng Zhang, Fangping Li, … Zhenling Zeng·Frontiers in Cellular and Infection MicrobiologyPeer-reviewed·Feb 26, 2021
- Genomic Surveillance of Acinetobacter baumannii in the Philippines, 2013-2014
Jeremiah Chilam, Silvia Argimón, … Celia Carlos·Western Pacific surveillance response journalPeer-reviewed·Oct 1, 2021
- Phylogenomic and phenotypic analyses highlight the diversity of antibiotic resistance and virulence in both human and non-human Acinetobacter baumannii
E. Sykes, V. Mateo-Estrada, … A. Kumar·bioRxiv·Dec 13, 2023
- The road less travelled: Exploring the genomic characteristics and antimicrobial resistance potential of Acinetobacter baumannii from the indigenous Orang Asli community in Peninsular Malaysia
Soo Sum Lean, Denise E. Morris, … Chew Chieng Yeo·bioRxiv·Jun 12, 2025